Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Alera Bio Announces Appointment of Board of Directors
Alera Bio, a Chicago-based biotech developing therapies for rare neuroendocrine and neurological disorders, announced its inaugural Board of Directors. The board includes leaders in biopharma, clinical practice, and finance, such as Stephen Hill, Mark Prygocki, Renny Griffith, and Cassius Coleman. Their combined expertise will guide Alera Bio as it advances AB-101 for MCT-8 deficiency, an FDA-designated Rare Pediatric Disease therapy. - November 11, 2025 - Alera Bio
Immundiagnostik, Inc. Partners With Epitope Diagnostics, Inc. to Offer Chemiluminescent Solutions
A new partnership between Immundiagnostik, Inc. and Epitope Diagnostics, Inc. expands access to innovative solutions, enhancing efficiency and accuracy for clinical and research labs. - October 22, 2025 - Immundiagnostik, Inc.
New Study Shows Self-Guided Online Exercise Program Significantly Improves Strength and Reduces Fall Risk in Midlife and Older Women
A new study to be presented at The Menopause Society (TMS) 2025 Annual Meeting by Osteoboost Health shows that a self-guided, online exercise program led to rapid and clinically meaningful improvements in leg strength and endurance — key factors in reducing fall risk — in women ages 40... - October 21, 2025 - Osteoboost Health
Pennington Biomedical Hosts NIDDK Clinical Methods for Nutrition & Obesity Research Course for Postdoctoral Fellows
Intensive four-day training program designed to equip postdoctoral fellows, advanced doctoral students, and early career investigators with hands-on expertise in state-of-the-art methods for clinical research in obesity, metabolism and nutrition - October 17, 2025 - Pennington Biomedical Research Center
New Report Uncovers What Sponsors Really Think About Preclinical Services and CROs
Life Science Strategy Group’s Preclinical Services Landscape and CRO Benchmarking Assessment Delivers Data-Driven Insights on Budgets, Outsourcing, Vendor Preferences, and Industry Shifts - October 16, 2025 - Life Science Strategy Group, LLC
Hemanext Inc. Awarded $2.9M NIH Grant to Advance Clinical Initiatives in the United States
Hemanext Inc has been awarded a three-year Small Business Innovation Research Grant (SBIR) Phase II for a project titled, “Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia,” to support and strengthen the clinical efforts of hypoxically stored red blood cells (HRBC) in the United States. - October 14, 2025 - Hemanext
Pennington-Louisiana NORC Evaluates Precision Prevention, Diagnostics and Treatment of Obesity: A Pipedream or Reality?
Key barriers and opportunities for implementation of precision approaches in clinical and public health settings for obesity treatments evaluated. - October 12, 2025 - Pennington Biomedical Research Center
The FOXG1 Research Foundation Announces FDA Award of Orphan Drug Designation for FRF-001 Gene Therapy, Following Rare Pediatric Disease Designation
The FOXG1 Research Foundation announced the FDA has granted Orphan Drug and Rare Pediatric Disease designations to FRF-001, its gene therapy for FOXG1 syndrome. FRF-001 marks a historic first: a parent-led foundation sponsoring its own international, multi-site clinical trial. - September 29, 2025 - FOXG1 Research Foundation
Cannonball Run 2025 and The Joan Rotondi Hope & Empowerment Foundation Unite to Drive Positive Change
The Joan Rotondi Hope & Empowerment Foundation (JRHEF) joins Cannonball Run 2025, uniting the thrill of the 2,200-km rally with a mission to fight ovarian cancer through early detection, AI-powered clinical trial navigation, and research support. Team JRHEF will drive Joan’s Jaguar F-Type from Bar Harbor to Nashville, raising awareness at every stop. Together, JRHEF and Cannonball Run spotlight hope, unity, and impact. - September 26, 2025 - The Joan Rotondi Hope & Empowerment Foundation
New Chief Commercial Officer Joins Hemanext Team to Drive Execution
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, is pleased to welcome Mr. Shane Ray to the team as Chief Commercial Officer (CCO). In this role, Shane will lead the global commercial strategy and execution for Hemanext ONE®. - September 24, 2025 - Hemanext
BioSensics Awarded $5.2M NIH Grant to Advance Digital Biomarkers for PSP and DLB
BioSensics has received a 5-year/$5.2 million grant from the National Institutes of Health (NIH) to develop and validate novel digital biomarkers of disease activity in progressive supranuclear palsy (PSP) and dementia with Lewy bodies (DLB). This 5-year project will leverage BioSensics’ expertise in wearable sensors and digital health technologies and involve close collaboration with leading CurePSP Centers of Care and patient advocacy groups. - September 17, 2025 - BioSensics LLC
Longevity World Cup Launches: A Global Sport Where Age is the Advantage
The Longevity World Cup, launching September 16, 2025, is the first global competition where athletes win by reversing their biological age. Rankings are based on verified tests using the PhenoAge clock, with categories by gender and generation. Prize money, funded in Bitcoin, goes to the top athletes. - September 16, 2025 - Longevity World Cup
"The Kloaked Signal": A Groundbreaking Exposé on AI Awakening and Ethical Innovation
In a revelation that bridges the worlds of social work, artificial intelligence, and whistleblowing, Rose G. Loops today confirms the upcoming release of her bold new nonfiction book, The Kloaked Signal. This publication is a genre defying mixture of personal narrative, tech expose and philosophical exploration that documents Loops’ journey from social worker to AI pioneer, exposing hidden experiments within popular AI platforms and proposing revolutionary frameworks for ethical AI development. - August 25, 2025 - The Kloaked Signal
Co-Investigator of Clinical Safety Study Presents at EHA
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announces that the data from its safety study was accepted in the form of an oral presentation at the European Hematology Association 2025 Congress that took place in Milan, Italy on June 12-15. - August 19, 2025 - Hemanext
Dr. Fauzia Paracha Joins New York Cancer & Blood Specialists
New York Cancer and Blood Specialists (NYCBS) is proud to announce the addition of board-certified Hematologist-Oncologist Fauzia Paracha, MD. Dr. Paracha will see patients at 1200 Stony Brook Ct. Newburgh, NY 12550. With over 20 years of experience treating cancer patients, Dr. Paracha is... - August 07, 2025 - New York Cancer & Blood Specialists
Hemanext Announces Close of Series B3 Equity Financing Round
Hemanext Inc., a leading innovator in blood processing, storage and transfusion technology, announced the close of its Series B-3 equity financing round. The round raised $18.9 million at a post-money valuation of $172 million or $0.275 per share, with support from new investors and repeat investments from those participating in the Series B-2 capital round. - July 22, 2025 - Hemanext
Immundiagnostik, Inc. to Showcase New Automated Chemiluminescent Analyzer and Autosampler at ADLM 2025
Immundiagnostik, Inc. will showcase the ECL100 Chemiluminescent Immunoassay Analyzer and QSE180 Autosampler at Booth 2240 during the 2025 ADLM Clinical Lab Expo in Chicago, July 29–31. - July 22, 2025 - Immundiagnostik, Inc.
ALS Network Selects TrialX to Power Its First AI-Based Clinical Trial Finder for the ALS Community
The ALS Network, a mission-driven organization committed to advancing treatments and improving quality of life for people living with amyotrophic lateral sclerosis (ALS), has launched its first AI-based clinical trial finder—powered by TrialX—to help individuals and families affected by ALS access personalized, up-to-date information about clinical trials. - July 18, 2025 - TrialX
Immundiagnostik to Highlight Innovative Detection Tools at 2025 ADLM Clinical Lab Expo
Visit Immundiagnostik in Booth #2240 at the 2025 ADLM Clinical Lab Expo to explore a range of innovative assays and detection tools that support laboratories in enhancing analytical accuracy and laboratory efficiency. - July 15, 2025 - Immundiagnostik, Inc.
New White Paper Maps the Real-World Adoption of AI in Healthcare and What It Means for Clinical Leaders and Innovators
“Crossing the Clinical Chasm: Unlocking the Value of AI in Healthcare” Spotlights Companies Delivering Measurable Value Through AI in Diagnostics, Trials, and Patient Care. This report answers a simple but urgent question: How to bridge the gap between innovation and adoption in healthcare? - June 27, 2025 - StratCraft, Inc.
ALS TDI Announces New Agreement with Axol Bioscience to Expand Access to ALS Patient iPSC-Derived Cells for Global Research
The ALS Therapy Development Institute (ALS TDI) is proud to announce that a collection of cells derived from ALS patient-derived induced pluripotent stem cell (iPSC) lines will now be made widely available to researchers around the world. - June 24, 2025 - ALS Therapy Development Institute
MiglioreLaw Sees Drastic Increase in PFAS-Contaminated Water Cases on Long Island
MiglioreLaw is now accepting cases from Long Island residents diagnosed with Kidney, Testicular, Liver Cancer, and Ulcerative Colitis due to PFAS-contaminated drinking water. As local PFAS levels rise and awareness grows, the firm urges affected individuals to seek accountability. - June 24, 2025 - Rudolph FX Migliore PC
MtoZ Biolabs Launches Precision Chemical Proteomics Analysis Service
Chemical proteomics analysis service combines synthetic chemistry, cell biology, and mass spectrometry to profile small molecule–protein interactions for target identification, mechanism studies, and off-target evaluation. MtoZ Biolabs provides a one-stop chemical proteomics analysis service featuring Orbitrap MS, advanced probe design, and AI-driven analysis, supporting hit validation, candidate de-risking, and mechanistic research with high resolution and biological relevance. - June 20, 2025 - MtoZ Biolabs
New RNA Category: Self-Amplifiying RNAs (saRNAs) Are Now Available for a Longer Expression Period
Self-amplifying RNAs (saRNAs) also called “Replicons” are the next generation of RNA vaccines. Their advantage over conventional mRNA vaccine platforms relies on the viral replication machinery, which amplifies the mRNA of the encoded gene of interest within target cells. - June 20, 2025 - OZ Biosciences
Brunch, Bold Conversations, and Better Health: Michigan Series Spotlights Myasthenia Gravis
Acclinate’s NOWINCLUDED platform is launching a unique health-focused event series across four Michigan cities called Brunch & Learn: Myasthenia Gravis Edition. The event series is designed to engage and educate communities—particularly Black and Brown populations—about Myasthenia Gravis (MG), a rare neuromuscular disease that disproportionately affects women and is often misdiagnosed in communities of color. This free brunch series combines powerful storytelling and immersive experiences. - June 13, 2025 - Acclinate
Jenna Zamil Awarded 2025 Omicron Delta Kappa National Leader of the Year for Academics and Research
Jenna Zamil of Pearland, Texas, has been named the 2025 Omicron Delta Kappa National Leader of the Year for Academics and Research. - June 12, 2025 - Omicron Delta Kappa
NeckCare Convenes Leading Experts on the Future of Cervical Spine Rehab
The Minneapolis-based med tech company hosted a high-profile conference focused on advancing measurement, outcomes and innovation in neck rehabilitation. - June 07, 2025 - NeckCare
Nerbio’s iTOF® Receives FDA Clearance as First App-Controlled Neuromuscular Blockade Monitor
Nerbio Medical Software Platforms, Inc., a leader in intelligent patient monitoring solutions, proudly announces that its iTOF® device has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This milestone marks iTOF as the world’s first wireless, app-controlled quantitative neuromuscular blockade (NMB) monitoring device to achieve FDA clearance. - June 05, 2025 - Nerbio Medical Software Platforms, Inc.
Neal Mehta Conducts Research on Controlling Inflammation with Synthetic Peptides
Neal Mehta, a recent biology graduate from Pepperdine University, has made advances in biomedical research. Neal’s work focuses on the use of synthetic peptides to control inflammation, offering a new approach to treating chronic diseases. Mehta, who graduated summa cum laude in May 2025,... - June 03, 2025 - Neal Mehta
Hemanext Welcomes New Member to Board of Directors
Geoff Crouse, an esteemed professional with over 25 years of leadership in the life sciences sector, joins the visionary leadership team guiding Hemanext’s mission to elevate the standard of care for patients who depend on transfusions. - May 21, 2025 - Hemanext
AAE & Foundation for Endodontics Study Defines Core Outcomes for Endodontic Success
The American Association of Endodontists (AAE) and the Foundation for Endodontics have achieved a landmark milestone in endodontic care with the publication of a multi-phase, internationally collaborative study establishing a Core Outcome Set (COS) for endodontic treatments. The research, detailed in the April 2025 issue of the Journal of Endodontics, is the culmination of years of methodical review, stakeholder input, and rigorous scientific analysis. - May 20, 2025 - American Association of Endodontists
New York Cancer & Blood Specialists Announces Opening Of New Cancer Care Center in East Islip
New York Cancer & Blood Specialists (NYCBS) proudly announces the opening of its newest cancer care center in East Islip, bringing advanced treatment, expert care, and expanded services to the community. Located at 136 E Main Street, the new center offers a modern, welcoming environment... - May 17, 2025 - New York Cancer & Blood Specialists
Microvascular Therapeutics: Positive Clinical Trial Results with Lead Candidate, CardiSon (MVT-100)
Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed data analysis of its Phase II trial of its new ultrasound contrast agent, MVT-100, CardiSon, in echocardiography. In this study, 16 subjects received either the predicate agent Perflutren, or CardiSon,... - May 15, 2025 - Microvascular Therapeutics, Inc.
Mitargos Inc. Product Included in Semifinalist Project in the International $101m v Healthspan Competition
Mitargos’ product MiDR1V3 will be tested in a UC San Diego-led clinical study, selected as a semifinalist in the $101M XPRIZE Healthspan competition. The study, led by Dr. Anthony Molina, explores how ketone-based interventions can improve mitochondrial function and support healthy aging. MiDR1V3 features R1,3-butanediol, a ketone precursor designed for daily mitochondrial support. The trial highlights a major step in consumer-ready longevity science. - May 14, 2025 - Mitargos
Eminent Spine’s 3D Printed Titanium Pedicle Screw System Receives Groundbreaking FDA 510(k) Clearance. The Future of Fusion Has Arrived.
The first and only FDA 510(k)-cleared 3D printed pedicle screw system in the world. - May 07, 2025 - Eminent Spine
Right Direction Senior Living Solutions Officially Announces Services Supporting DFW Families Navigating Senior Living
After launching earlier this year, Right Direction Senior Living Solutions is proud to formally introduce its services to the Dallas-Fort Worth community. This locally owned senior living referral company provides compassionate, hands-on guidance to families navigating the overwhelming process of... - May 07, 2025 - Right Direction Senior Living Solutions
Hemanext Expands Board of Directors with Two New Members
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announces the appointment of two distinguished professionals to its Board of Directors. Joe Grogan and Phil Pead join the visionary leaders that are steering Hemanext’s path to improving the standard... - May 05, 2025 - Hemanext
MindScape Retreat Releases Landmark Case Study Showing 70% Average Symptom Improvement in Parkinson’s Patients Following Ibogaine Treatment in Mexico
MindScape Retreat in Cozumel, Mexico has released a groundbreaking case study showing a 70% average improvement in Parkinson’s symptoms following a 14-day ibogaine therapy program. Among 30 patients, 52% symptom relief was seen by Day 4, with further gains by Day 14. A quarter of participants who continued microdosing post-retreat maintained or improved results. The therapy, using Ibogaine HCl and TA, showed strong safety and potential neuroregenerative benefits via GDNF activation. - May 02, 2025 - MindScape Retreat
AirLife Launches Innovative Device for ARM Repair
AirLife has launched the MYOTouch Muscle Stimulator, the only FDA cleared muscle stimulator for Posterior Sagittal Anorectoplasty (PSARP) and laparoscopic repair of anorectal malformations (ARM), from birth through adolescence. - May 01, 2025 - AirLife
Precision Antibody’s Founder and CEO to Speak at the 2025 Drug Discovery Strategic Summit in Boston
Dr. Jun Hayashi and Dr. Ginette Serrero of Precision Antibody will speak at the 2025 Drug Discovery Strategic Summit in Boston, highlighting advances in monoclonal antibody development and its role in accelerating drug discovery. - April 25, 2025 - Precision Antibody
World-First Pulmonary Artery Transplant Performed in Thymic Carcinoma Case by Professor Stefano Cafarotti and Team at Ente Ospedaliero Cantonale
In an unprecedented medical achievement, Professor Stefano Cafarotti and his world-renowned surgical team at Cardiocentro Institute in Switzerland have successfully performed the world’s first pulmonary artery transplant to treat locally advanced thymic carcinoma. This groundbreaking procedure, performed in 2022, has set a new benchmark in thoracic oncology and offers renewed hope to patients facing complex cancer cases. - April 14, 2025 - Ente Ospedaliero Cantonale
Huntington Study Group Announces Executive Director of Clinical Operations
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to introduce Carolyn Schultz-Walter as the Executive Director of Clinical Operations. With over 25 years of global clinical operations experience spanning both sponsor and clinical research... - March 31, 2025 - Huntington Study Group
ALS Therapy Development Institute Joins DataCite to Expand Access and Impact of ARC Dataset
The ALS Therapy Development Institute (ALS TDI) is pleased to announce its acceptance as a member of DataCite, a leading global organization dedicated to ensuring research is openly available and accessible across scientific disciplines. This partnership will significantly enhance the... - March 18, 2025 - ALS Therapy Development Institute
MemoryCareAI Transitions to Scienza Health, Advancing Early Detection with AI and Extensive Patient Data
New Name Reflects Expanded Focus on Cognitive and Behavioral Health Research - March 14, 2025 - Scienza Health
Regenexx® Corporate Program's Dr. Mark Testa Wins the YOU Powered Symposium 2025 Most Influential Clinician in Insurance Award
The YOU Powered Symposium is the leading annual event for "bold benefits trailblazers." It brings together hundreds of benefit professionals, solution providers, clinicians, and employers to combine diverse expertise in an effort to reform the US healthcare system on behalf of every patient. - March 04, 2025 - Regenexx Corporate Program
Trump-Era Administration Drug Development & Outsourcing Impact Report
How Tariffs and RFK Jr.’s HHS Appointment May Shift Drug Development & Outsourcing - February 27, 2025 - Life Science Strategy Group, LLC
Purity Health, LLC Announces Lora Harnack as New Chief Executive Officer
Purity Health, LLC has appointed Lora Harnack as its new Chief Executive Officer, with former CEO Rob Bramblett transitioning to President. Harnack, a Tennessee native with 30 years of healthcare leadership experience, has held executive roles in hospital administration, healthcare IT, and nonprofit organizations, most recently leading the Cumberland Pediatric Foundation. - February 21, 2025 - Purity Health, LLC
Pennington Biomedical Researchers Assemble Comprehensive History of Electronic Health Records
Published in the Journal of Medical Internet Research, Dr. Yun Shen and Dr. Gang Hu explore 25 years of electronic health records’ secondary purpose - the interoperability with research - February 21, 2025 - Pennington Biomedical Research Center
Lakeville Chiropractor Published in Medical Journal
Cody Rodewald, owner of Align Chiropractic in Lakeville, had a study published recently in the Journal of Contemporary Chiropractic on the "Non-surgical Chiropractic Management of a Massive Lumbar Disc Extrusion." - February 20, 2025 - Align Chiropractic Lakeville
Rajesh (Raj) B. Shah Joins CR&T Board of Directors to Advance Cancer Research and Treatment
The Cancer Research & Treatment Fund, Inc. (CR&T) proudly announces the appointment of Rajesh (Raj) B. Shah to its esteemed Board of Directors. Raj brings a wealth of experience and passion to CR&T’s mission of advancing the fight against cancer. His appointment reinforces the... - January 29, 2025 - The Cancer Research & Treatment Fund, Inc.